Could Forest's DDMAC Letter For Off-Label Promotion Doom CEO Solomon?

A physician complained to FDA's "Bad Ad" program about a Forest Laboratories sales representative's off-label claims for the fibromyalgia drug Savella.

More from Archive

More from Pink Sheet